Previous studies have revealed that K17 promotes tumor progression in numerous cancer types, including gastric cancer, non-small cell lung cancer, oral squamous cell carcinomas and Ewing sarcoma (8, 9, 22–25). This evidence concerns the gene KRT17 and oral cavity squamous cell carcinoma.